SEC Form 4 · accession 0001179110-17-001834
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Bisaro
Director
Period of report
Feb 2, 2017
Accepted (ET)
Feb 6, 2017 · 8:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F2 | Feb 2, 2017 | A | 444 | $229.52 | A | 305,900 | D | |
| Ordinary Shares, par value $0.0001 | holding | — | — | — | 120,000 | I | Paul Bisaro LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units shall vest 100% on the earlier of (i) the day before the 2017 Annual Shareholder Meeting or (ii) May 4, 2017.
- F2Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.